Literature DB >> 32643167

Monitoring the community use of antibiotics in Italy within the National Action Plan on antimicrobial resistance.

Agnese Cangini1, Filomena Fortinguerra1, Aurora Di Filippo1, Andrea Pierantozzi1, Roberto Da Cas2, Federico Villa3, Francesco Trotta1, Maria Luisa Moro4, Carlo Gagliotti4.   

Abstract

BACKGROUND: In Italy both the consumption of antibiotics and the prevalence of bacterial resistance are higher than in other European countries. In 2017, the first National Action Plan on Antimicrobial Resistance (PNCAR) was adopted in Italy. In response to the PNCAR two national reports on antibiotic use in the human setting have been published. This article's aim is to describe the pattern of antibiotic consumption in the community setting in Italy from 2013 to 2018.
METHODS: To analyse the consumption for reimbursed antibiotics dispensed by community pharmacies different data sources were used. Consumption was measured in terms of defined daily dose (DDD), prescriptions or prevalence of use.
RESULTS: In 2018, the consumption of antibiotics in Italy amounted to 16.1 DDD per 1000 inhabitants per day. The rates of consumption by geographical area were: 12.7 DDD in the north, 16.9 in the centre and 20.4 in the south. The use was greater in the extreme age groups than in the population aged from 20 to 64 years. The consumption was higher in winter season, with high peaks in the incidence of flu syndromes. In the paediatric population, a utilization rate of 1010 prescriptions per 1000 children, with a prevalence of use of 40.8%, was found.
CONCLUSION: The study provides useful information on the geographical variability of antibiotic use in Italy to guide decision makers in the introduction of tailored interventions, as suggested by PNCAR, aimed at promoting a more rational use of antibiotics for humans and reducing antimicrobial resistance.
© 2020 The British Pharmacological Society.

Keywords:  antibiotics; antimicrobial resistance; antimicrobial stewardship; drug utilization; prescriptions

Mesh:

Substances:

Year:  2020        PMID: 32643167     DOI: 10.1111/bcp.14461

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

Review 1.  Antimicrobial resistance: new insights and therapeutic implications.

Authors:  Bashir Ahmad Sheikh; Basharat Ahmad Bhat; Manzoor Ahmad Mir
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-19       Impact factor: 5.560

2.  Using Belgian pharmacy dispensing data to assess antibiotic use for children in ambulatory care.

Authors:  Hannelore Dillen; Ruben Burvenich; Tine De Burghgraeve; Jan Y Verbakel
Journal:  BMC Pediatr       Date:  2022-01-03       Impact factor: 2.567

3.  Trend of Antibiotic Use in Children with Acute Otitis Media in Korea.

Authors:  Kyu Hyun Park; Seung-Ah Choe; Ju-Young Shin; Young June Choe
Journal:  J Korean Med Sci       Date:  2021-11-29       Impact factor: 2.153

Review 4.  Place in Therapy of the Newly Available Armamentarium for Multi-Drug-Resistant Gram-Negative Pathogens: Proposal of a Prescription Algorithm.

Authors:  Lorenzo Volpicelli; Mario Venditti; Giancarlo Ceccarelli; Alessandra Oliva
Journal:  Antibiotics (Basel)       Date:  2021-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.